The KAVI-Institute of Clinical Research (KAVI-ICR) was honoured to host Linda Muringo, Sales and Applications Director, and Ruth Kariuki, Applications Specialist and Sales, from Excella Biotechnologies Limited on a recent courtesy visit. The meeting brought together researchers and industry representatives to explore opportunities for stronger collaborations in advancing scientific research.

Present from KAVI-ICR were Dr. Noel Onyango, NCDs Lead, and George Ichoho, Junior Research Fellow, who engaged in a productive discussion with the Excella team on the evolving research and diagnostics landscape.

A key highlight of the discussions was the recognition of the shifting dynamics in research funding, which continue to shape how institutes conduct studies across diverse health priorities, including oncology, infectious diseases, and non-communicable diseases. Both parties emphasised the importance of building mutually beneficial relationships between research institutions and suppliers.

Ms. Muringo and Ms. Kariuki highlighted how Excella Biotechnologies, as a dedicated scientific partner, aims to support research through reliable products, technical expertise, and timely solutions. In turn, Dr Onyango and Mr Ichoho emphasised that close collaboration with suppliers is crucial in ensuring that KAVI-ICR researchers can access the tools and support they need to generate impactful scientific outcomes.

Such meetings underscore the importance of dialogue between researchers and suppliers. By aligning with institutional needs and anticipating research challenges, partnerships can be better structured to improve research quality, efficiency, and innovation.

KAVI-ICR remains committed to fostering strong collaborations with stakeholders across the scientific ecosystem—encompassing academia, industry, and development partners—to deliver research that transforms health outcomes in Kenya and beyond.

The KAVI-Institute of Clinical Research (KAVI-ICR) was honoured to host Linda Muringo, Sales and Applications Director, and Ruth Kariuki, Applications Specialist and Sales, from Excella Biotechnologies Limited on a recent courtesy visit. The meeting brought together researchers and industry representatives to explore opportunities for stronger collaborations in advancing scientific research.

Present from KAVI-ICR were Dr. Noel Onyango, NCDs Lead, and George Ichoho, Junior Research Fellow, who engaged in a productive discussion with the Excella team on the evolving research and diagnostics landscape.

A key highlight of the discussions was the recognition of the shifting dynamics in research funding, which continue to shape how institutes conduct studies across diverse health priorities, including oncology, infectious diseases, and non-communicable diseases. Both parties emphasised the importance of building mutually beneficial relationships between research institutions and suppliers.

Ms. Muringo and Ms. Kariuki highlighted how Excella Biotechnologies, as a dedicated scientific partner, aims to support research through reliable products, technical expertise, and timely solutions. In turn, Dr Onyango and Mr Ichoho emphasised that close collaboration with suppliers is crucial in ensuring that KAVI-ICR researchers can access the tools and support they need to generate impactful scientific outcomes.

Such meetings underscore the importance of dialogue between researchers and suppliers. By aligning with institutional needs and anticipating research challenges, partnerships can be better structured to improve research quality, efficiency, and innovation.

KAVI-ICR remains committed to fostering strong collaborations with stakeholders across the scientific ecosystem—encompassing academia, industry, and development partners—to deliver research that transforms health outcomes in Kenya and beyond.